- Trials with a EudraCT protocol (49)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
49 result(s) found for: Additive effect.
Displaying page 1 of 3.
EudraCT Number: 2006-004427-11 | Sponsor Protocol Number: 060317 | Start Date*: 2006-10-27 |
Sponsor Name:Univ of Lund, Dept of Pediatrics | ||
Full Title: Effects of Omega-3-Fatty Acids on Arterial Endothelial Function and Intima Media Thickness in Children with Insulin-Dependent Diabetes Mellitus | ||
Medical condition: Diabetes mellitus type 1 in children | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003377-97 | Sponsor Protocol Number: KLLVACC-2018 | Start Date*: 2018-12-18 |
Sponsor Name:Swedish CLL-group | ||
Full Title: Long term effect on immune response after pneumococcal vaccination in patients with chronic lymphocytic leukemia and evaluation of the effect of revaccination. | ||
Medical condition: The aim of the study is to evaluate pneumococcal vaccination strategy with PPSV23 and PCV13 in patients with chronic lymphocytic leukemia (CLL) initially randomized in a clinical study. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004674-27 | Sponsor Protocol Number: 14076 | Start Date*: 2007-02-14 | |||||||||||
Sponsor Name:Dutch Kidney Foundation | |||||||||||||
Full Title: Effect of GM-CSF on development of antigen-specific T cell responses following hepatitis B vaccination | |||||||||||||
Medical condition: Haemodialysis patients are susceptible for infections due to a continuous mildly activated immune system. About 40% of the haemodialysis patients does not respond to the standard HBV vaccination pr... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010863-18 | Sponsor Protocol Number: NL26548.101.09 | Start Date*: 2010-06-25 | |||||||||||||||||||||
Sponsor Name:Amphia ziekenhuis | |||||||||||||||||||||||
Full Title: The additive effect of short contact tar-derivates to UVB therapy in “en plaque” psoriasis: a prospective single blind unicenter randomized clinical trial | |||||||||||||||||||||||
Medical condition: Psoriasis patient getting UVB lighttherapy in a dermatological daycare center | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002175-42 | Sponsor Protocol Number: GernerDex001 | Start Date*: 2011-10-12 |
Sponsor Name:Paracelsus Medizinische Universität - Universitätsklinik für Anästhesie | ||
Full Title: The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks for shoulder surgery | ||
Medical condition: The goal of the present study is to investigate the safety and efficiacy of dexmedetomidine added to ropivacaine for interscalene brachial plexus nerve block for shoulder surgery in humans. Provi... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002756-21 | Sponsor Protocol Number: 1663/2020 | Start Date*: 2021-02-23 |
Sponsor Name:Department of Cardiothoracic Anesthesia and Intensive Care Medicine, Medical University of Vienna | ||
Full Title: Plasma Pharmacokinetics of Prophylactic Cefazolin Administered for Cardiac Surgery: Comparison of Cardiopulmonary Bypass Priming with Additive Human Albumin 20% vs.Pure Crystalloid Priming: A singl... | ||
Medical condition: This is a pharmacokinetic trial for patients undergoing cardiac surgery. It will be investigated whether cardiopulmonary bypass priming substituted with human albumin 20% has an effect on the pharm... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-000869-38 | Sponsor Protocol Number: VGSKAS-12916 | Start Date*: 2008-06-02 |
Sponsor Name:Skaraborg Hospital | ||
Full Title: Impact of Losartan in hypertensive men with obstructive sleep apnea | ||
Medical condition: Hypertension and obstructive sleep apnea (OSA) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006948-65 | Sponsor Protocol Number: Version 4 | Start Date*: 2007-11-29 |
Sponsor Name:University Hospitals of Leicester NHS Trust | ||
Full Title: The effect of acidosis correction and exercise on tissue wasting and immune function in renal patients | ||
Medical condition: Chronic kidney disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-005814-28 | Sponsor Protocol Number: 17099.2901 | Start Date*: 2008-11-24 |
Sponsor Name:Erasmus MC | ||
Full Title: Cost-effectiveness of viscosupplementation therapy for patients with osteoarthritis of the knee: a randomized clinical trial | ||
Medical condition: osteoarthritis of the knee | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005231-28 | Sponsor Protocol Number: 31121976-1 | Start Date*: 2008-10-01 |
Sponsor Name:Med. Univ. Wien, Universitätsklinik für Anästhesie, allgemeine Intensivmedizin und Schmerzmedizin | ||
Full Title: Postoperative Analgesie and Antihyperalgesia of Tramadol and Acetaminophen peroral after Caesarean Section | ||
Medical condition: Pain after Cesarean Section in spinal anesthesia | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-021188-34 | Sponsor Protocol Number: LT2380-PIII-05/10 | Start Date*: 2011-07-01 | |||||||||||||||||||||
Sponsor Name:Laboratoires Théa | |||||||||||||||||||||||
Full Title: Efficacy and safety assessment of intracameral T2380 (Fixed combination of lidocaine, phenylephrine and tropicamide) for mydriasis and anaesthesia in phacoemulsification cataract surgery | |||||||||||||||||||||||
Medical condition: The aim of this clinical study will be to develop a combination of active substances enabling to obtain at the same time a mydriasis and an anaesthesia during cataract surgery | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: PT (Completed) DE (Completed) BE (Completed) AT (Completed) ES (Ongoing) SE (Completed) IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007881-45 | Sponsor Protocol Number: SPP100ANL02T | Start Date*: 2009-03-12 | ||||||||||||||||
Sponsor Name:University Medical Center Groningen | ||||||||||||||||||
Full Title: A double-blind, placebo-controlled, randomized trial investigating the safety and efficacy of Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients w... | ||||||||||||||||||
Medical condition: Patients with chronic heart failure and reduced glomerular filtration rate. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-004142-35 | Sponsor Protocol Number: ABSALON | Start Date*: 2023-04-18 | |||||||||||
Sponsor Name:Department of Ophthalmology, Rigshospitalet | |||||||||||||
Full Title: Additive Benefits of Semaglutide for open-AngLe glaucoma – an Opportunity for Neuroprotection (ABSALON) | |||||||||||||
Medical condition: mild and moderate glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002600-18 | Sponsor Protocol Number: 43/2007/O/Sper | Start Date*: 2007-06-05 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: EVALUATION OF THE RELATIONSHIP BETWEEN INFLAMMATION-PHYSICAL ACTIVITY AND THE ACTIVITY OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS | |||||||||||||
Medical condition: Abdominal obesity with metabolic syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002010-35 | Sponsor Protocol Number: TinnEx | Start Date*: 2006-12-14 |
Sponsor Name:Prof. Herta Flor, Head of the Institute of Clinical and Cognitive Neuroscience | ||
Full Title: An Extinction Training in Tinnitus | ||
Medical condition: The effect of pregabalin on the success to reduce the interference by tinnitus by an extinction training is tested in chronic tinnitus sufferers. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001888-21 | Sponsor Protocol Number: DPM-CF-203 | Start Date*: 2004-12-03 |
Sponsor Name:Pharmaxis Ltd | ||
Full Title: A cross-over comparative study of inhaled mannitol, alone and in combination with daily rhDNase, in children with cystic fibrosis | ||
Medical condition: Cystic fibrosis (CF) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-000990-35 | Sponsor Protocol Number: FARM12.PW7R_A6-DeprEpil | Start Date*: 2019-02-06 | |||||||||||
Sponsor Name:DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA | |||||||||||||
Full Title: EFFECTS OF ANTIDEPRESSANT TREATMENT WITH AGOMELATINE ON PATIENTS AFFECTED BY DEPRESSION AND EPILEPSY. A DOUBLE BLIND RANDOMIZED STUDY WITH ACTIVE CONTROL (ESCITALOPRAM) WITH PARALLEL GROUPS. | |||||||||||||
Medical condition: Depression in patients affected by epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003321-32 | Sponsor Protocol Number: 108 | Start Date*: 2021-01-21 | |||||||||||
Sponsor Name:Hvidovre Hospital, Dep. of Orthopaedic Surgery | |||||||||||||
Full Title: Evaluation of intra articular Tranexamic acid for reduction of total blood loss in total hip arthroplasty | |||||||||||||
Medical condition: The benefit of additional Tranexamic Acid (TXA) injected intra-articular at the end of surgery for patients undergoing a unilateral total hip arthroplasty in addition to conventional IV TXA to redu... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000559-15 | Sponsor Protocol Number: FB2012 | Start Date*: 2012-09-14 |
Sponsor Name:FinnBladder | ||
Full Title: TREATMENT OF Ta BLADDER CANCER WITH HIGH RISK OF RECURRENCE – FLUORESCENCE CYSTOSCOPY WITH OPTIMIZED ADJUVANT MITOMYCIN-C | ||
Medical condition: bladder cancer (non-invasive Ta urothelial bladder cancer) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-012642-22 | Sponsor Protocol Number: 0887x1-20003 | Start Date*: 2009-12-18 |
Sponsor Name:Swedish CLL-group | ||
Full Title: A Randomized Phase III Trial to Determine Whether Conjugated Pneumococcal Vaccine Can Improve the Immune Responsiveness Compared to Polyclonal Pneumococcal Vaccine in Patients With Untreated Chroni... | ||
Medical condition: The purpose of the study is to determine wheter patients with chronic lymphocytic leukaemia (CLL) will benefit from vaccination with conjugated pneumococcal vaccine compared to conventional 23-vale... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
